Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
35.09
+0.64 (1.86%)
At close: Jan 27, 2026, 4:00 PM EST
35.50
+0.41 (1.17%)
After-hours: Jan 27, 2026, 7:15 PM EST
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $3.82 billion as of January 27, 2026. Its market cap has increased by 796.89% in one year.
Market Cap
3.82B
Enterprise Value
3.52B
1-Year Change
796.89%
Ranking
Category
Stock Price
$35.09
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $3.82B, an increase of 2,557.64%. That is a compound annual growth rate of 93.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 3.82B | -13.14% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | 143.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 4.34B |
| ADMA Biologics | 3.98B |
| Ligand Pharmaceuticals | 3.96B |
| Arcellx | 3.91B |
| NewAmsterdam Pharma Company | 3.78B |
| Centessa Pharmaceuticals | 3.69B |
| Viking Therapeutics | 3.64B |
| Liquidia | 3.53B |